Abcentra LLC, a clinical-stage biopharmaceutical company, has named Timothy Wright, MD as its new director, it was reported on Wednesday.
Wright is the general partner at Time Bioventures and is a rheumatologist and drug developer. He has served in various senior leadership roles in research and development at Pfizer, Novartis, California Institute for Biomedical Research (Calibr/Scripps Research), and Regulus Therapeutics. He has served as chief of Rheumatology at the University of Pittsburgh.
Wright completed his MD, post-doctoral clinical, and research training at Johns Hopkins.
OncoHost receives BIG Innovation Award in Health category
MemorialCare hospitals recognised in 2026 Women's Choice Awards
Champions Oncology expands bioanalytical services with new technology and leadership
PhaseV receives three industry honours for AI in clinical development
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025